FIDELITY MSCI HEALTH CARE INDEX ETF (FHLC)
An exchange-traded fund listed on AMEX. A fund is not a company: it has no filed accounts of its own here, and it is never ranked beside companies. Every figure below is market data, with the day it was supplied.
Price
Last close 85.06 USD on Oct 15, 2026. Market data, supplied Oct 15, 2026.
What it costs
| Expense ratio | 0.08% |
| Assets under management | 3.54B USD |
| Net asset value per share | 83.46 USD |
| Inception | Oct 21, 2013 |
| Sponsor | Fidelity |
| Asset class | Equity |
| Holdings the fund reports | 365 |
Market data, supplied Oct 15, 2026.
What it holds
The largest 25 by weight of the 348 holdings in the snapshot of Oct 15, 2026. A fund is marked as a fund, and a holding that is not a company's share (a bond, a bill, cash, an option or a swap) is marked as not a company.
| # | Holding | Weight |
|---|---|---|
| 1 | ELI LILLY & CO | 13.02% |
| 2 | JOHNSON & JOHNSON | 8.34% |
| 3 | ABBVIE INC | 6.76% |
| 4 | MERCK & CO INC NEW | 4.89% |
| 5 | UNITEDHEALTH GROUP INC | 4.78% |
| 6 | THERMO FISHER SCIENTIFIC INC | 3.44% |
| 7 | AMGEN INC | 3.11% |
| 8 | GILEAD SCIENCES INC | 2.56% |
| 9 | ABBOTT LABORATORIES | 2.49% |
| 10 | PFIZER INC | 2.25% |
| 11 | SECURITIES LENDING CF | 2.16% |
| 12 | INTUITIVE SURGICAL INC | 2.08% |
| 13 | DANAHER CORP | 1.98% |
| 14 | VERTEX PHARMACEUTICALS INC | 1.72% |
| 15 | MEDTRONIC PLC | 1.66% |
| 16 | BRISTOL-MYERS SQUIBB CO | 1.61% |
| 17 | MCKESSON CORP | 1.57% |
| 18 | CVS HEALTH CORP | 1.56% |
| 19 | STRYKER CORP | 1.36% |
| 20 | ELEVANCE HEALTH INC | 1.29% |
| 21 | REGENERON PHARMACEUTICALS INC | 1.08% |
| 22 | CIGNA GROUP (THE) | 1.04% |
| 23 | MODERNA INC | 1.02% |
| 24 | HCA HEALTHCARE INC | 1.00% |
| 25 | BOSTON SCIENTIFIC CORP | 0.90% |
Market data, supplied Oct 15, 2026.
Sector weights
| Healthcare | 98.87% |
| Technology | 0.65% |
| Cash & Others | 0.45% |
| Financial Services | 0.03% |
Market data, supplied Oct 15, 2026.
Country weights
| United States | 97.11% |
| Ireland | 2.14% |
| United Kingdom | 0.37% |
| Other | 0.21% |
| Canada | 0.07% |
| Switzerland | 0.07% |
| Netherlands | 0.04% |
Market data, supplied Oct 15, 2026.
Look-through value
Earnings yield, P/E and book yield of the holdings taken together: n/a. Look-through figures are not measured for this fund yet.